acoustic shockwave therapy pain relief electromagnetic wave shock wave therapy for heel pain

Erectile dysfunction, or ED, is when it is hard to get or keep an erection that's firm enough for sex. ED affects as many as 30 million men.

Most men have problems with erections from time to time. But when this happens more than half of the time, then ED is present. ED can happen when health problems limit blood flow or damage nerves in the penis. ED can also be caused by stress or emotional reasons. ED can be an early warning of a more serious illness. Heart disease, high blood pressure and high blood sugar can all cause ED. Finding and treating the cause(s) of your ED can help your overall health and well-being.

What is EDSWT?
Erectile Dysfunction Shock Wave Therapy (EDSWT) is an innovative approach to vasculogenic ED, a device that uses advanced acoustics technology.
EDSWT utilizes low-intensity extracorporeal shock waves, focusing on blood vessels and encouraging neovascularization in the penis shaft and crus.
The low-intensity shock waves help relieve vascular deficiency, a common cause of erectile dysfunction.

EDSWT: New Effectivness For More Patients:

Vasculogenic and diabetic ED patients will benefit from EDSWT. EDSWT therapy brings hope to those patients, by allowing more than 70% of them to become responsive to PDE5 inhibitors.

As “end-stage” ED patients, they will be able to enjoy normal sexual functionality. Our shockwave therapy machine breakthrough therapeutic system can bring lasting improvement in erectile function and new sexual spontaneity to millions – painlessly, naturally and safety.

EDSWT Shock wave therapy Benefits

EDSWT does not involve the use of any pharmaceuticals. Moreover, the shock wave treatment causes no side-effects or systemic load on other organs and healthy tissues.

The non-invasive, painless EDSWT procedure is performed during a series of brief visits to the urology office, and requires no sedation or anesthesia.

Discernable improvement in the erectile function of the penis can be visible within two weeks after therapy begins.

Recent clinical studies revealed that patients reported a high rate of satisfaction for more than two years after treatment – all without reliance on PDE5 inhibitors.

In clinical tests, EDSWT has shown significant long-term effectiveness. These results are confirmed by a double-blind placebo controlled study of a large group of patients.